Hospitality Roundtable
Due to digital footprints becoming as significant as physical presence, nowadays customer reviews have become a cornerstone in the hospitality industry’s strategy to attract and retain guests. A recent ACOR study highlighted this trend, revealing that 97 percent of hotel guests consider other customer reviews before booking, making it nearly as crucial as the…
Latest
Experts Talk
AAHOACON24 Seeks to Help Hotel Owners and Operators Overcome Challenges and Maximize Opportunities
As the hospitality industry anticipates AAHOACON 2024, a pivotal gathering, hotel owners and operators find themselves on the cusp of transformative change. The industry, Having weathered the storm of pandemic-driven shifts, faces a landscape dotted with daunting challenges and unprecedented opportunities. Innovations in technology, shifting market dynamics, and evolving consumer expectations are sculpting a…
Articles
Hotels & the Hospitality Industry Need Innovative Tech Strategies to Grow in 2024
The hospitality industry is on the brink of transformation as it faces 2024 and technology is going to be a major factor in that change. Last year’s challenges, including the muted growth in the U.S. hotel market, have paved the way for innovative strategies to enhance hotel performance. Where did 2023 leave the hospitality…
Latest
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
Targeting T Cells Within the Cancer Immunity Cycle
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…
Inside Oncology Drug Development: Overcoming Resistance with Science
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…